Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

 110.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 148.50p
  • 52 Week Low: 101.00p
  • Currency: UK Pounds
  • Shares Issued: 106.23m
  • Volume: 56,952
  • Market Cap: £116.85m
  • RiskGrade: 258

Thursday broker round-up UPDATE

Date: Thursday 23 Jan 2014

LONDON (ShareCast) - Afren: Investec ups target price from 170p to 200p and maintains a buy recommendation.

AG Barr: Investec raises target price from 585p to 620p retaining an add rating. Canaccord Genuity ups target price from 630p to 650p and keeps a buy recommendation.

Arbuthnot: Numis downgrades from add to hold with a target price of 1074p.

ASOS: Goldman Sachs downgrades to neutral.

Bovis Homes Group: Bank of America upgrades to buy.

British Land: Liberum Capital shifts target price from 724p to 732p and retains a buy recommendation.

Carphone Warehouse: UBS ups target price from 280p to 310p maintaining a buy recommendation.

Cello Group: Sanlam Securities takes target price from 94p to 105p and reiterates its buy recommendation.

Croda International: Barclays upgrades to equal-weight.

Derwent London: Liberum Capital raises target price from 2676p to 2849p, while staying with its hold recommendation.

easyJet: Investec increases target price from 1675p to 1750p, while downgrading from buy to hold.

Great Portland Estates: Liberum Capital takes target price from 612p to 637p and retains a hold recommendation.

Hammerson: Liberum Capital moves target price from 605p to 617p and reiterates a buy recommendation. Morgan Stanley upgrades to equal-weight.

Henderson Group: Citi raises target price from 205p to 226p retaining its neutral rating.

Henry Boot: WH Ireland ups target price from 260p to 290p and keeps a buy recommendation. Investec ups target price from 200p to 260p and maintains a buy recommendation.

Intu Properties: Liberum Capital lowers target price from 319p to 313p maintaining its hold recommendation.

Jupiter Fund Management: Societe Generale upgrades to buy with a target price of 450p.

Land Securities: Liberum Capital moves target price from 1056p to 1068p retaining its hold recommendation.

London Mining: JP Morgan cuts target price from 195p to 170p, while its overweight rating is kept.

London Stock Exchange: Numis places its hold recommendation under review.

Mitchells & Butlers: Numis Numis ups target price from 500p to 525p, but downgrades from buy to add.

Marks & Spencer: Exane upgrades to outperform.

National Grid: JP Morgan raises target price from 735p to 805p and leaves its neutral rating unaltered.

Novae Group: Canaccord Genuity increases target price from 575p to 645p maintaining a buy recommendation.

Paypoint: Canaccord Genuity takes target price from 1200p to 1326p keeping a buy recommendation.

Pearson: Investec places both its target price (prev.: 1325p) and its add recommendation under review.

Pennon Group: Credit Suisse takes target price from 610p to 630p and retains an underperform rating.

Petra Diamonds: Investec places its target price (prev.: 151p) under review, while its buy recommendation is kept.

PZ Cussons: Numis cuts target price from 388p to 376p and retains a hold recommendation.

SAB Miller: Citi reduces target price from 3200p to 3100p downgrading to neutral.

Segro: Liberum Capital ups target price from 346p to 364p, while leaving its hold recommendation unchanged.

Severn Trent: Credit Suisse cuts target price from 1580p to 1540p downgrading to underperform.

Shaftesbury: Liberum Capital increases target price from 636p to 649p and maintains a hold recommendation.

Smith (WH): Citi raises target price from 1050p to 1180p and stays with its buy recommendation. JP Morgan takes target price from 1085p to 1115p and maintains an overweight rating.

St James's Place: Numis downgrades from add to hold with a target price of 805p.

Super Group: Investec increases target price from 1500p to 1800p leaving its buy recommendation unchanged.

United Utilities: Credit Suisse ups target price from 660p to 680p keeping its neutral rating.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 110.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 148.50p
52 Week Low 101.00p
Volume 56,952
Shares Issued 106.23m
Market Cap £116.85m
RiskGrade 258

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
64.69% below the market average64.69% below the market average64.69% below the market average64.69% below the market average64.69% below the market average
83.78% above the sector average83.78% above the sector average83.78% above the sector average83.78% above the sector average83.78% above the sector average
Price Trend
21.22% above the market average21.22% above the market average21.22% above the market average21.22% above the market average21.22% above the market average
12.2% below the sector average12.2% below the sector average12.2% below the sector average12.2% below the sector average12.2% below the sector average
Income
26.26% below the market average26.26% below the market average26.26% below the market average26.26% below the market average26.26% below the market average
86.67% above the sector average86.67% above the sector average86.67% above the sector average86.67% above the sector average86.67% above the sector average
Growth
39.24% below the market average39.24% below the market average39.24% below the market average39.24% below the market average39.24% below the market average
38.89% below the sector average38.89% below the sector average38.89% below the sector average38.89% below the sector average38.89% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Oct-19 25-Apr-19
Paid 01-Nov-19 24-May-19
Amount 1.15p 2.75p

Trades for 09-Apr-2020

Time Volume / Share Price
16:31 25,000 @ 110.00p
16:06 25,000 @ 110.00p
15:57 608 @ 111.64p
15:45 1,897 @ 112.00p
14:39 4,450 @ 109.06p

Cello Health Key Personnel

CEO Mark Scott

Top of Page